Development of novel antiviral peptides against dengue serotypes 1-4

QR Code

Development of novel antiviral peptides against dengue serotypes 1-4

Dengue infections pose a critical threat to public health worldwide. Since there are no clinically approved antiviral drugs to treat dengue infections caused by the four dengue virus (DENV) serotypes, there is an urgent need to develop effective antivirals. Peptides are promising antiviral candidate...

Full description

Bibliographic Details
Main Authors:	Lee, Michelle Felicia, Anasir, Mohd Ishtiaq, Poh, Chit Laa *
Format:	Article
Published:	Elsevier 2023
Subjects:	RA Public aspects of medicine
Online Access:	http://eprints.sunway.edu.my/2157/

Similar Items

Antiviral peptides against dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022)

Molecular Mechanisms of Antiviral Agents against Dengue Virus
by: Lee, Michelle Felicia, et al.
Published: (2023)

Structure-based design of antivirals against Envelope Glycoprotein of dengue virus
by: Anasir, M. I. *, et al.
Published: (2020)

Innate and adaptive immune evasion by dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022)

Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)

Antiviral activity of silymarin in comparison with baicalein against EV-A71
by: Lalani, S.*, et al.
Published: (2020)

Development of antivirals and vaccines against enterovirus 71 (EV-A71)
by: Poh, Chit Laa *
Published: (2018)

Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)

Role of microRNAs in antiviral responses to dengue infection
by: Wong, Rui Rui, et al.
Published: (2020)

Strategies to improve the physicochemical properties of peptide‑based drugs
by: Lee, Michelle Felicia *, et al.
Published: (2023)

Peptides as therapeutic agents for dengue virus
by: Chew, Miaw Fang *, et al.
Published: (2017)

Development of peptide vaccines in dengue
by: Reginald, Kavita*, et al.
Published: (2017)

Development of dengue vaccines
by: Lim, Chee Siean *, et al.
Published: (2018)

Inhibition of Enterovirus 71 (EV-71 infections by a novel antiviral peptide derived from EV-71 capsid protein VP1
by: Tan, Chee Wah, et al.
Published: (2012)

Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
by: Abdul Aziz, Al-Fattah Yahaya *, et al.
Published: (2023)

Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021)

Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020)

Structural vaccinology for viral vaccine design
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)

Identification of B-cell epitopes for eliciting neutralizing antibodies against the SARS-CoV-2 spike protein through bioinformatics and monoclonal antibody targeting
by: Lim, Hui Xuan *, et al.
Published: (2022)

In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
by: Pourianfar, Hamid Reza, et al.
Published: (2012)

A novel antiviral peptide against avian influenza virus H9N2.
by: Yusoff, Khatijah, et al.
Published: (2008)

Enhancement of tetravalent immune responses to highly conserved epitopes of a dengue peptide vaccine conjugated to polystyrene nanoparticles
by: Chan, Yanqi, et al.
Published: (2020)

Cloning and expression of prM and it's use to distinguish host immune responses against dengue virus and Japanese encephalitis virus infections
by: Wang, Seok Mui
Published: (2001)

The conserved molecular determinants of virulence in dengue virus
by: Zuleeza A,, et al.
Published: (2019)

Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)

Evaluation for antiviral potential of ficus deltoidea against dengue virus type-2
by: Yuan, Seng Wu, et al.
Published: (2024)

Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials
by: Lim, Hui Xuan *, et al.
Published: (2021)

Predictors for early detection of severe Dengue with shock / Quah Chai Hoong
by: Quah, Chai Hoong
Published: (2019)

Birdcages source of dengue virus
by: Medical, Xpress
Published: (2016)

Development of multi-epitope peptide-based vaccines against SARS-CoV-2
by: Lim, Hui Xuan *, et al.
Published: (2020)

The Predictive And Diagnostic Accuracy Of Pentraxin-3 And Vascular Endothelial Growth Factor In Severe Dengue
by: Low, Gary Kim Kuan
Published: (2019)

Antiviral activity of traditional Chinese medicinal plants Dryopteris crassirhizoma and Morus alba against dengue virus
by: Maryam, Maqsood, et al.
Published: (2020)

Exploring bioflavonoids as novel antivirals against Chikungunya virus / Rafidah Lani
by: Rafidah, Lani
Published: (2016)

Enterovirus specific anti-peptide antibodies
by: Poh, Chit Laa *, et al.
Published: (2015)

Molecular docking of SP40 peptide towards cellular receptors for enterovirus 71 (EV-A71)
by: Masomian, Malihe *, et al.
Published: (2021)

Risk factors associated with development of dengue haemorrhagic fever or dengue shock syndrome in adults in Hospital Tengku Ampuan Afzan Kuantan
by: Tee, H. P., et al.
Published: (2009)

Clinical manifestations of dengue in relation to dengue serotype and genotype in Malaysia: a retrospective observational study
by: Chee, Hui Yee, et al.
Published: (2018)

Comparative Transovarial transmission of dengue virus serotypes 1, 3 and 4 in wild type and transgenic Aedes Aegypti females mosquitoes
by: Suria Marlina, Mansor
Published: (2014)

C-reactive protein : determinant value predicting length of stay in dengue patient attending emergency department HUSM Kubang Kerian
by: Md Supian, Badrul Hisham
Published: (2015)

How to cope with dengue in the developing countries like Pakistan?
by: Sohail, Filza, et al.
Published: (2011)